|
|
|
|
|
|
|
|
|
In a perfect world, patients enrolled in clinical trials would live a short distance from the investigator site where they receive their treatment. Unfortunately, that is not always the case and sometimes circumstances arise that prevent patients from keeping their appointments. In recent years the Direct-to-Patient model, which brings medical procedures and protocols to a patient?s home, has emerged as a potential solution for sponsors to increase patient recruitment and retention in clinical trials.
Download this case study to learn how close collaboration between a sponsor company and the Patheon Logistics team maximized engagement by delivering critical protocols directly to patients? homes and ensuring they remained enrolled in the clinical trial.
|
|
|
|
|
|
|
Thermo Fisher Scientific, 4815 Emperor Blvd., Durham, NC 27703-8470, USA
+1 866-728-4366 | +1 919-226-3200 | Contact Us | Privacy Policy
|
|
|
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Technology, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.
|
|
